Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

CABA — Cabaletta Bio, Inc. Dilution Risk Tracker

Track CABA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CABA — Get alerts when the score changes →

As of October 13, 2026, Cabaletta Bio, Inc. (CABA) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Cabaletta Bio, Inc. has a market capitalization of $272.97M, 169.55M shares outstanding, 112 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $150.00M, 53.09M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
10
📊 Float Risk
22
⚠️ Warrant Exposure
70
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
📜 Warrant Exercise model 50%
• Massive warrant overhang: 31% of shares outstanding
• Elevated warrant risk score (70/100)
💰 Capital Raise model 18%
• Active ATM program with $150M remaining capacity
🔔 Track CABA — Get forecast alerts →

Market Data

Market Cap$272.97M
Shares Outstanding169.55M
Float142.90M
Cash$225.10M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding169.55MVerified float table or market cache
Public Float142.90MVerified float table or market cache
Market Cap$272.97MMarket data cache
Cash Runway24.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$150.00MSEC-derived dilution fields
Outstanding Warrants53.09MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 3, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 18.8% shares (2026Q1 vs prior)
112 institutional holders · 97.34M shares
#1 T. Rowe Price Investment Management, Inc. 11.08M shares
#2 Bain Capital Life Sciences Investors, LLC 9.68M shares
#3 JENNISON ASSOCIATES LLC 8.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest38.61M
Days to Cover6.3
% of Float27.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2020-03-30
8-K 8K EVENT 2026-05-04
424B5 ATM 2026-05-04
4 INSIDER TRANSACTION 2026-03-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CABA Dilution Snapshot

Cabaletta Bio, Inc. (CABA) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CABA's DilutionScore is currently 32/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 22/100 (Low risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202632/100MEDIUM14 days
Aug 22 – Sep 29, 202622/100LOW39 days
Aug 14 – Aug 21, 202638/100MEDIUM7 days
Jul 16 – Aug 13, 202634/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CABA shares outstanding have increased 69.4% from 96.27M (Mar 2026) to 163.05M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 2026163.05M142.90M▲ 46.47%
May 08, 2026163.05M97.56M▲ 7.01%
Mar 27, 2026111.32M91.17M▲ 11.07%
Mar 25, 202696.27M82.08M▲ 15.64%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CABA Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CABA files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CABA — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CABA
CABA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.